Provided by: Centre for Medicines Research (CMR) International
Access reliable, comprehensive, and up-to-date data to uncover clinical trial trends and insights, gathered by the Centre for Medicines Research (CMR) International, a wholly owned subsidiary of Clarivate. The 2020 CMR International Pharmaceutical Clinical Factbook brings together proprietary data from leading Pharma and Biotech companies – of all sizes and therapy areas – to provide objective information and actionable insights to position your clinical trials for success with trusted expert analysis. 74% of top 50 pharma rely on CMR’s 20+ years of experience to inform their R&D and clinical decisions.
Benchmark your trials against industry leaders and competitors to make more strategic decisions for your pipeline. Access comprehensive, proprietary data including:
Regional and country-level comparisons of trends in clinical trials
Trends in clinical trial durations between 2014-2018 by phase and therapeutic area
Proportion of clinical trials with protocol amendments, by phase
Median cost per subject treated, by phase
Trends in clinical trial outsourcing
Utilize presentation-ready “rich-data” Microsoft Powerpoint files that provide the results in a clear, easily understood format. Each slide is accompanied by a succinct explanation of the methodology used and the definitions applied. Take advantage of the 50+ robust charts, tables and graphs that are exportable to other applications, and drill down to the underlying data in each interactive chart or graph with the click of a mouse to analyze the figures behind the trend.
Provide access to the “rich-data” enterprise Powerpoint file to unlimited users within your organization. Install the file on your company network or intranet or distribute it openly to any employee in your organization.
Quickly see who’s innovating in what space across pharma with the definitive up-to-date business planning tool for decision makers in R&D, corporate finance, business strategy, marketing, clinical operations or corporate communications.
Easily and efficiently find full-text articles and search for references. Generate references, citations and bibliographies in a whole range of journal styles with just a few clicks.
Systematically prioritize the repositioning of all known drugs for an indication of interest using a unique computational model that combines extensive bioinformatics and commercial evidence with advanced proprietary analytics.
Prioritize indications for a new or repurposed asset and systematically find the most meaningful candidates across thousands of indications, leveraging chemical, biological, clinical, regulatory and commercial data points.
